2024台灣腦中風學會非維他命K拮抗劑口服抗凝血劑用於心房纖維顫動病人腦中風預防治療指引更新

2024 Update of the 2019 Taiwan Stroke Society Guideline on the Use of Non-Vitamin K Antagonist Oral Anticoagulants for Prevention of Stroke in Patients with Atrial Fibrillation

林雅如(Ya-Ju Lin) ； 崔百青(Pai-Ching Tsui) ； 蔡欣熹(Hsin-Hsi Tsai) ； 鍾芷萍(Chih-Ping Chung) ； 陳柏安(Bo-An Chen) ； 郭書帆(Shu-Fan Kuo) ； 王淳民(Chun-Min Wang) ； 吳秀娟(Hsiu-Chuan Wu) ； 宋碧姍(Pi-Shan Sung) ； 林慧娟(Huey-Juan Lin) ； 蔡力凱(Li-Kai Tsai) ； 連立明(Li-Ming Lien) ； 鄭建興(Jiann-Shing Jeng) ； 傅維仁(Helen L. Po) ； 心房纖維顫動預防腦中風治療指引共識小組(Taiwan Stroke Society Guideline Consensus Group)

《台灣中風醫誌》 6卷1期 (2024/03) Pp. 1-65

https://doi.org/10.6318/FJS.202403_6(1).0001

並列摘要

The incidence and prevalence of atrial fibrillation (AF) are increasing in Taiwan and globally. It is the most common sustained cardiac arrhythmia. Non-vitamin K antagonist oral anticoagulants (NOACs) have become the anticoagulants of choice for preventing stroke in patients with AF. However, there are still many unanswered questions about how to optimally use these drugs in specific clinical situations. Recommendations from the 2012, 2016, and 2019 Taiwan Stroke Society (TSS) guidelines have been updated to provide new evidence to guide clinicians. The TSS Guidelines Consensus Group updated the guideline after a systematic review and in-depth discussion. This guideline is based on the data of the Taiwanese and Asian populations and the recent guidelines of the European Heart Rhythm Association, American Heart Association, American College of Cardiology and Asia Pacific Heart Rhythm Society.

並列關鍵字

stroke prevention ； non-vitamin K antagonist oral anticoagulant ； atrial fibrillation ； left atrial appendage occlusion ； ESUS